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Abstract
Background: Bacterial intercellular communication, called quorum sensing, takes place via the production and
collective response to signal molecules. In Gram-negative bacteria, like Pseudomonas aeruginosa, these signaling
molecules are N-acylhomoserine lactones (AHLs). P. aeruginosa is a common cause of inflammation of the ear canal
(otitis externa) in dogs. It employs quorum sensing to coordinate the expression of host tissue-damaging factors,
which are largely responsible for its virulence. The treatment of P. aeruginosa-associated otitis is challenging due to
a high intrinsic resistance of P. aeruginosa to several antibiotics.
Attenuation of quorum sensing signals to inhibit bacterial virulence is a novel strategy for the treatment of resistant
bacterial pathogens, including P. aeruginosa. Therefore, it is important to recognize and define quorum sensing
signal molecules in clinical samples. To date, there are no reports on determination of AHLs in the veterinary clinical
samples. The purpose of this study was to validate an analytical procedure for determination of the concentration
of AHLs in the ear rinses from dogs with P. aeruginosa-associated otitis externa.
Samples were obtained with rinsing the ear canals with physiological saline solution. For validation, samples from
healthy dogs were spiked with none or different known amounts of the selected AHLs. With the validated procedure,
AHLs were analyzed in the samples taken in weekly intervals from two dogs, receiving a standard treatment for P.
aeruginosa-associated otitis externa.
Results: Validation proved that the procedure enables quantification of AHLs in non-clinical and clinical samples. In
addition, a time dependent reduction of AHL concentration was detected for the treated dogs.
Conclusions: Our results indicate that liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is
superior in detecting AHLs compared to other chromatographic techniques. This is the first report on determination of
AHLs in the clinical samples of veterinary importance. The analytical procedure described in this paper is capable of
supporting novel antimicrobial strategies, which target quorum sensing.
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Background
Pseudomonas aeruginosa is an important opportunistic
pathogen of humans and animals, causing severe infec-
tions when the immune system is compromised [1, 2],
or after long-lasting antibiotic treatments, injuries and
medical procedures [3, 4]. P. aeruginosa is a Gram-
negative bacterium ubiquitously present in the water
and soil. It is naturally resistant to penicillin and amino-
penicillins, and to the first and second generations of
cephalosporins. It is usually susceptible to aminoglyco-
sides, fluoroquinolones, lipopeptides, ureidopenicillins,
carboxypenicillins, carbapenems, and cephalosporins of
the third generation [5]. The resistance of P. aeruginosa,
however, can rapidly develop against any antibiotic [5].
Behavior of bacteria is coordinated, at the level of mi-
crobial community, by their gene expression at the
intra-species level or less commonly between species.
Such coordination of communal behavior is controlled
through the production and detection of signal mole-
cules or autoinducers, which is called quorum sensing
(QS) [6–10]. The QS system defines the expression of
various bacterial phenotypes, depending on the local
density of bacterial population, including the virulence
factors, biofilm formation and resistance to antibiotics
[11]. It is associated with pathogenesis of various
diseases in humans and animals, and has a clinically
evident effect in human cystic fibrosis (CF) [12], endo-
carditis and osteomyelitis in rabbits [13, 14], bovine
mastitis [15], gastrointestinal diseases [9], and ear canal
infections, dermatitis and other secondary infections in
dogs [16].
The secondary factors, including Malassezia spp.
(yeasts), and bacteria of the genera Staphylococcus, Pro-
teus, Streptococcus and Pseudomonas, often cause com-
plications to the inflammation of the ear canal (otitis
externa, OE) in dogs [17, 18]. Involvement of P. aerugi-
nosa in OE (P. aeruginosa-associated OE, PaOE) in-
creases the morbidity, prolongs the treatment, and
reduces the possibility of a favorable outcome [19, 20].
The ability of P. aeruginosa to produce biofilms and
synchronize its virulence through QS is very important
for the conservation and/or perpetuation of infection
[21]. The long and narrow ear canal of dogs represents a
very suitable environment for P. aeruginosa colonization
and the subsequent activation of its QS [7].
One or several signal molecules may be involved in QS.
In Gram-negative bacteria, the most common are N-
acylhomoserine lactones (AHLs or AI-1) [9, 10, 22, 23]. P.
aeruginosa QS system shows a hierarchical arrangement
with las system controlling rhl [6–8, 24–28]. It mainly
produces N-(3-oxododecanoyl)-L-homoserine lactone (3-
oxo-C12-HSL) and N-butanoyl-L-homoserine lactone
(C4-HSL), whereas production of N-hexanoyl-L-homoser-
ine lactone (C6-HSL) and shorter 3-oxo-HSLs (3-oxo-C6-
HSL, 3-oxo-C8-HSL and 3-oxo-C10-HSL) is less abun-
dant [29, 30]. It was shown that 3-oxo-C12-HSL has the
most critical role, as it regulates the expression of several
genes involved in activation of the subordinate rhl system,
where C4-HSL is the most significant autoinducing mol-
ecule [6]. In addition to its signalling function, 3-oxo-C12-
HSL also exerts antibacterial activities against some other
pathogens [31] and a direct immunomodulatory effect on
the mammal host [32], itself functioning as a virulence de-
terminant [33] and contributing to the establishment of
chronic infections [34]. Under some growth conditions,
activation of the las system does not precede the activa-
tion of rhl, but just the opposite, indicating the environ-
mental dependence of their hierarchy [35]. There are
various layers of sophistication to P. aeruginosa AHL-
dependent QS [34, 36] and approximately 10 % of P. aeru-
ginosa genome is directly or indirectly regulated by this
multi-signal QS system [37]. Some genes are las specific,
some rhl, and others respond to both 3-oxo-C12-HSL and
C4-HSL [37]. In addition, at least four QS signalling
mechanisms were reported to comprise P. aeruginosa QS
network, being modulated in accordance to the environ-
mental cues, also of host origin, influencing the virulence
phenotypes of P. aeruginosa [36].
Detection of signal molecules associated with QS
could serve as an indicator for the severity of infection,
success of a treatment, and to estimate the outcome of
disease [22]. Disruption of QS, called quorum quenching
(QQ) [38], could represent a therapeutic tool, comple-
menting or substituting the antibiotic treatment, which
would reduce the risk for the development of antibiotic
resistance [39]. It was shown that QQ can be achieved
through the enzymatic destruction of QS signals, devel-
opment of antibodies to QS signal molecules, or via
agents which block QS [40]. The inhibitors of QS would
reduce bacterial pathogenicity, also by increasing the
susceptibility of existing biofilms to antibiotics or phago-
cytosis, and increase effectiveness of the host immune
system [39, 41, 42]. Identifying molecules involved in QS
in the clinical samples is, therefore, of great importance.
Several reports describing chemical analytical methods
for the identification and quantification of selected
AHLs are available. The use of a thin layer chroma-
tography [7, 12]; gas chromatography with mass spec-
trometry (GC-MS) [43, 44]; high-performance liquid
chromatography (HPLC) with UV detection [6], mass
spectrometry (MS) [12], or coupled with tandem MS
(MS/MS) [22, 45]; nuclear magnetic resonance (NMR)
[26]; and colorimetry [46] was reported. In addition, a
bacterial biosensor system for the detection of AHLs
was also described [9]. Although a number of analytical
methods were developed, only a few are applicable for de-
termination of low AHL concentrations in clinical samples
[22]. Determination of AHLs in physiological samples or
Kušar et al. BMC Veterinary Research  (2016) 12:233 Page 2 of 11
complex biological matrices is more complicated than
in bacterial culture supernatants due to the interfer-
ence from matrix, causing most of the analytical
problems [7, 9, 12, 22]. The mechanisms behind this
phenomenon, commonly referred to as matrix effects
and leading to signal suppression or enhancement,
are still under investigation due to the great variety
of available matrices and the unpredictable effect they
might have on the final result [47]. Hence, data defining
pathophysiological concentrations of AHLs in the clinical
samples have not been often reported. In picomolar to mi-
cromolar concentrations, AHLs were discovered in the
sputum [7, 12], mucopurulent secretions of respiratory
tract [48], lung tissue of patients with CF [49], and saliva
and faeces of individuals with gastrointestinal disorders
[22]. To the best of our knowledge, no reports were pub-
lished regarding detection of QS signal molecules in veter-
inary clinical samples.
In the present work, the analytical procedure for deter-
mination of AHLs of P. aeruginosa from canine OE
clinical samples was introduced and validated. It consisted
of the extraction of AHLs (3-oxo-C12-HSL, C4-HSL and
C6-HSL) from the ear rinses and their quantification using




Solid standard substances C4-HSL, C6-HSL and 3-oxo-
C12-HSL with certified purity of 97 % (Sigma-Aldrich,
St. Louis, MO, USA) were used. Stock standard solu-
tions of individual AHLs with the concentration of
1 mg/ml (C4-HSL, C6-HSL) and 0.91 mg/ml (3-oxo-
C12-HSL) were prepared in methanol. Mixed working
standard solutions for preparing the calibration curve
containing all the three selected AHL signal molecules,
each at the concentration from approx. 1 to 60 ng/ml,
were prepared in a mixture of methanol and deionized
water (35 + 65). Dichloromethane used for the extraction
of AHLs and methanol used for the mobile phase were
of analytical and chromatography grade purity, respect-
ively (Merck, Darmstadt, Germany). As the mobile
phase, a gradient mixing of methanol and deionized
water containing 0.1 % formic acid (Merck) was used.
For the rinsing of canine ear canals, saline solution
(0.9 % NaCl) was employed.
Sample collection and preparation
Samples were obtained by rinsing the ear canals of dogs
with saline solution (30 ml). The collected samples were
adjusted to the final volume of 30 ml by sterile saline,
centrifuged at 3100 × g for 30 min at 4 °C, and the
supernatants were stored at −80 °C till extraction.
For validation, the ear rinses from healthy dogs spiked
with known amounts of C4-HSL, C6-HSL and 3-oxo-
C12-HSL were used. None of the samples contained
AHLs in detectable concentrations prior to spiking. An
aliquot of 0.320 ml of the mixed working standard
solution containing AHLs in concentrations of approx.
60 ng/ml (61.5 ng/ml of C4-HSL and C6-HSL, 56.9 ng/ml
of 3-oxo-C12-HSL) was added to 10 ml of the super-
natant, giving the final concentrations of approx. 2 ng/ml
(1.97 ng/ml of C4-HSL and C6-HSL, 1.82 ng/ml of 3-oxo-
C12-HSL). Thus, a 10-ml sample contained approx. 20 ng
of each AHL (19.7 ng of C4-HSL and C6-HSL, 18.2 ng of
3-oxo-C12-HSL).
To test the validated analytical procedure with clinical
samples, the ear rinses of two PaOE dogs, collected
weekly during the treatment, were used. Samples were
taken during a scheduled veterinary checkup at the pri-
mary clinic or at the university clinic. As a control, the
ear rinse from a healthy dog was employed.
Analytical procedure
For the extraction of AHLs from the ear rinses, a proced-
ure used for determination of AHLs in sputum [7, 12] was
modified. One third (10 ml) of a 30-ml sample was
extracted three times with 10-ml portions of dichloro-
methane. The combined extracts were evaporated to
dryness at 60 °C using the vacuum evaporator (Syncore
Reactor R-48, Büchi, Flawil, Switzerland). The residue
was dissolved in 1 ml of the mixture of methanol and
deionized water (35 + 65).
The particular AHLs were determined by LC-MS/MS
at conditions described elsewhere [22, 45]. In brief, elu-
tion of the column was performed with a mixture of
methanol–water. The mixing was isocratic for 4 min
(35 % methanol, 65 % deionized water), followed by a
linear gradient of methanol concentration from 35 to
95 % in 4 min and then back to 35 % in 1 min. The fol-
lowing 2 min, the column was washed again with the
mixture of methanol and water (35 + 65). The mobile
phase flow rate was 0.25 ml/min, injection volume 10 μl,
and column temperature 30 °C. Detection with MS was
performed in the positive ion mode. Voltage at the capil-
lary was 0.4 kV. The monitored ions and other parame-
ters are given in Table 1. Measurements were performed
with the liquid chromatography system Acquity (Waters,
Milford, MA, USA) equipped with an analytical column
ZORBAX Eclipse C18, Rapid Resolution HD, 1.8 μm,
2.1 × 100 mm (Agilent, Santa Clara, CA, USA) and mass
selective detector Xevo TQ MS (Waters).
Validation procedure
To perform the linearity test, and to determine the limit
of detection (LOD) and the limit of quantification
(LOQ), the mixed working standard solutions of AHLs
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at concentrations from approx. 1 to 60 ng/ml were used,
corresponding to AHL concentrations of approx. 0.1 to
6 ng/ml in the ear rinses. The estimation of LOD and
LOQ was based on visual evaluation, testing concentra-
tions in the target range expected for AHLs in clinical
samples. The LOQ estimate was defined as the lowest
amount or concentration of an analyte that is reasonably
achievable according to the target range and should be
regarded as the reporting limit; LOD was estimated as
one third (30 %) of LOQ [50].
The repeatability of results was tested by analyzing five
replicates of the ear rinse sample with the addition of
C4-HSL, C6-HSL and 3-oxo-C12-HSL at 1.97 ng/ml
(C4-HSL, C6-HSL) and 1.82 ng/ml (3-oxo-C12-HSL).
The analyses were performed at the same day and by the
same operator. For testing the within-laboratory repro-
ducibility, five replicates of the sample were prepared for
two more times by two operators at two different days.
The results obtained from these experiments were also
used for determination of the recovery.
Statistical procedures
The mean xð Þ for each AHL was calculated. The repeat-
ability and the within-laboratory reproducibility were
expressed by standard deviation (sr and sR, respectively)
and relative standard deviation (RSDr and RSDR, respect-
ively). The RSDR values were compared to the values
calculated from the Horwitz equation (RSD = 2(1 − 0.5
log C)), taken as a reference. The recovery was calculated
according to the equation rec %ð Þ ¼ 100 xa , where a
represents the spiked concentration of the analyte in the
sample [50, 51].
Culture examination
Prior to rinsing the ears of PaOE affected dogs with ster-
ile saline, cotton-swab samples were taken from the ears
for bacteriological examination. Samples were inoculated
onto blood agar plates (Columbia agar; Oxoid LTD,
Basingstoke, Hampshire, England) supplemented with
5 % sheep blood and incubated aerobically at 37 °C for
48 ± 2 h. After 24-h and 48-h incubation, plates were
examined for the growth of Pseudomonas spp. and other
pathogenic bacteria. Colonies morphologically consistent
with P. aeruginosa were subcultured on fresh blood agar
plates for subsequent identification. Bacterial isolates
were identified using the methods described by Quinn
and colleagues [52]; biochemical characteristics of the
isolates were determined using the commercial kit Api
20 NE (BioMérieux, France) according to the manufac-
turer’s instructions.
Results
In Figs. 1, 2 and 3, chromatograms of individual AHL
standard solutions C4-HSL (19.7 ng/ml), C6-HSL
(19.7 ng/ml) and 3-oxo-C12-HSL (18.2 ng/ml) are pre-
sented, respectively. Retention times of C4-HSL, C6-HSL
and 3-oxo-C12-HSL were 1.99, 4.76 (4.77) and 9.16 min,
respectively (Figs. 1, 2 and 3, Table 1). For each AHL, two
transitions of the precursor to product (fragment) ion are
shown (e.g., for C4-HSL 172.096 to 101.980 and 172.096
to 144.073). In the figures, the common display of LC-
MS/MS chromatograms, with the x-axis showing time
and y-axis the relative signal intensity (relative to the high-
est peak in chromatogram, in %), was adopted.
Equations describing the calibration lines were y = 2027x
+ 708 (C4-HSL), y = 2603x + 2039 (C6-HSL) and y = 1594x
+ 204 (3-oxo-C12-HSL). Regression coefficients of the cali-
bration curves were 0.999, 0.998 and 0.999, respectively.
Based on the responses obtained, the lowest calibration
point (1 ng/ml – or 0.1 ng/ml when referring to 10-ml vol-
umes) was estimated as the lowest quantifiable concentra-
tion. Therefore, LOQ for 10-ml samples was estimated
to 0.1 ng/ml (1 ng per 10-ml sample) and LOD accord-
ingly lower to 0.03 ng/ml (0.3 ng per 10-ml sample).
Expressed in molar concentrations, LOD and LOQ
were approx. 175 pM and 584 pM for C4-HSL (with
molar mass of 171.2 g/mol), 151 pM and 502 pM for
C6-HSL (199.2 g/mol), and 101 pM and 336 pM for 3-
oxo-C12-HSL (297.4 g/mol), respectively. Thus, with
LOD in the range of 100–200 pM and LOQ in 300–600
pM, LC-MS/MS was confirmed suitable for the purpose
as picomolar to micromolar concentrations were re-
ported for clinical samples [7, 12, 22, 48, 49].
Table 1 LC-MS/MS parameters
AHL Retention time [min] Precursor ion m/za Product ion m/za Cone voltage [V] Collision cell voltage [V]
C4-HSL 1.99 172.096 101.980 18 10
172.096 144.073 18 8
C6-HSL 4.76 (4.77) 200.160 101.984 18 10
200.160 98.986 18 6
3-oxo-C12-HSL 9.16 298.266 102.038 26 12
298.266 197.138 26 14
am/z: mass-to-charge ratio
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In Tables 2 and 3, parameters of the repeatability and
reproducibility test are given. Recoveries, calculated
from the results obtained under the within-laboratory
reproducibility conditions, were 54 , 89 and 79 % for C4-
HSL, C6-HSL and 3-oxo-C12-HSL, respectively. Before
calculations, the outliers were excluded using the
Grubbs statistical test [50].
When the analytical procedure for determination of
C4-HSL, C6-HSL and 3-oxo-C12-HSL was successfully
validated, the ear rinses (clinical samples) obtained from
a healthy dog (negative control) and two dogs with
PaOE (positive samples) were analyzed. In Figs. 4 and 5,
a chromatogram of the negative control and an example
of C4-HSL chromatogram belonging to a positive sam-
ple from the PaOE diseased dog are shown, respectively.
The positive-sample chromatogram clearly shows a peak
belonging to C4-HSL (Fig. 5), which is missing in the
negative-control chromatogram (Fig. 4). It should be
recalled that the y-axis scales are in relative units
(normalized to the largest peak), resulting in the
jagged line reflecting only the background noise in
Fig. 4. The largest peak was 7.800 × 102 units in Fig. 4
and 5.161 × 105 units in Fig. 5, therefore the signal
was approx. 1000-times higher in the positive sample
than in the negative.
In Table 4, the total masses of C4-HSL, C6-HSL and
3-oxo-C12-HSL determined in the ear rinses of two dogs
with PaOE collected at weekly intervals during the treat-
ment (week 0, 1, 2, 3, 4, 6 and 8) are given. The contents
of C6-HSL and 3-oxo-C12-HSL were distinctly lower
than of C4-HSL, making useful only the measurements
of C4-HSL contents. In the first dog, the content of C6-
HSL was much lower than of C4-HSL, but roughly
correlated to fluctuations of C4-HSL; C6-HSL masses
were close to LOQ (1 ng per 10-ml sample; week 0–3),
but also below LOQ (week 8) or even LOD (0.3 ng per
10-ml sample; week 4 and 6). Surprisingly, the content
of 3-oxo-C12-HSL was always below LOD. In the sec-
ond dog, the contents of C6-HSL and 3-oxo-C12-HSL
were below LOD but reached LOQ (C6-HSL) or LOD
(3-oxo-C12-HSL) in the third and fourth week, which
was in congruence with the increased C4-HSL levels.
In the first dog, the content of C4-HSL decreased in
the first month of treatment, but then slightly increased
in the sixth week and markedly in the eighth week of
treatment (Table 4). At that time (week 6 and 8), a sec-
ondary infection of the ear canal was also observed by
culture examination, showing the presence of two differ-
ent P. aeruginosa strains. In the second dog, the disease
management started with C4-HSL below LOD (day 0),
Fig. 2 LC-MS/MS chromatogram of C6-HSL (N-hexanoyl-L-homoserine lactone) standard solution with the concentration of 19.7 ng/ml. Transitions
200.16 > 101.984 and 200.16 > 98.986 are shown. Description of the axes as in Fig. 1
Fig. 1 LC-MS/MS chromatogram of C4-HSL (N-butanoyl-L-homoserine lactone) standard solution with the concentration of 19.7 ng/ml. Transitions
172.096 > 101.98 and 172.096 > 144.073 are shown. The x-axis represents retention time (min) and y-axis the relative intensity of signal (relative to
the highest peak in chromatogram, %)
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but its content increased after the first week of treat-
ment (Table 4). The time coincided with isolation of
Proteus mirabilis from the ear swab. In the second week
of treatment, the content of C4-HSL decreased and P.
mirabilis was no longer detected by culture examination.
In the third and fourth week, however, a marked in-
crease of C4-HSL content could be observed, with the
appearance of additional P. aeruginosa strain (already in
week 2) and the reappearance of P. mirabilis. Later, in
the second month of the treatment, the content of C4-
HSL decreased and the secondary infection was resolved
(week 6 and 8).
Discussion
The present study demonstrated that AHL signal mole-
cules can be quantified in the ear rinses of PaOE af-
fected dogs using LC-MS/MS. This method proved
superior when compared to other chromatographic
techniques that were tested in the scope of our prelimin-
ary validation experiments: GC-MS [43, 44] and HPLC
with UV detection [6]. Namely, of the three methods
selected for determination of AHLs in OE clinical
samples only LC-MS/MS enabled determination of
signal molecules at target concentrations. Two major
(3-oxo-C12-HSL, C4-HSL) and one minor (C6-HSL)
AHL of P. aeruginosa were monitored. Identification
of AHLs in clinical samples can have an important
diagnostic, therapeutic and prognostic value in human
and veterinary medicine.
The detection and quantification limits of the analyt-
ical procedure were low enough (LOD: 0.03 ng/ml;
LOQ: 0.1 ng/ml) to enable determination of C4-HSL,
C6-HSL and 3-oxo-C12-HSL in the ear rinses from dogs
with PaOE. The linearity of the procedure was con-
firmed with the regression coefficient of the calibration
curve higher than 0.995. The precision, repeatability and
the within-laboratory reproducibility, of the procedure
was expressed by standard deviations s [ng] and relative
standard deviations RSD [%]. Two outliers were elimi-
nated based on the Grubbs test [50], both belonging to
the 3-oxo-C12-HSL measurements from the same day of
validation. The resulting RSDR values for C4-HSL
(35 %), C6-HSL (22 %) and 3-oxo-C12-HSL (20 %) were
compared to the reference values derived from the
Horwitz equation: for the tested concentration of
2 ng/ml, the reference RSDR value was 41 % [50, 51].
Since the obtained RSDR values were below 41 %, the
reproducibility was considered satisfactory.
The recoveries of C4-HSL, C6-HSL and 3-oxo-C12-
HSL at the concentration of 2 ng/ml were 54, 89 and
79 %, respectively. Regarding requirements for the
performance of analytical procedures (e.g., Decision
2002/657/EC [51]), the recoveries of C6-HSL and 3-oxo-
C12-HSL were considered satisfactory; whereas the
recovery of C4-HSL (54 %) was suboptimal (it should be
70–110 %). Similar recovery values were reported previ-
ously [7]. The suboptimal recovery of C4-HSL should
not be considered a significant limiting factor, because
the analytical procedure was primarily used for monitor-
ing the changes in AHL concentrations with time and
not to determine their absolute values. However, the
obtained recovery values can be used for the correction
of results to achieve a good approximation of the actual
contents in a sample whenever appropriate.
Fig. 3 LC-MS/MS chromatogram of 3-oxo-C12-HSL (N-(3-oxododecanoyl)-L-homoserine lactone) standard solution with the concentration of
18.2 ng/ml. Transitions 298.266 > 102.038 and 298.266 > 197.138 are shown. Description of the axes as in Fig. 1
Table 2 Parameters obtained within the repeatability test
Replicate C4-HSL C6-HSL 3-oxo-C12-HSL
Average mass [ng] in 10-ml sample 11.3 19.9 15.6
sr [ng] 5.7 2.2 2.8
RSDr [%] 50.2 11 18
Table 3 Parameters obtained within the reproducibility test
Replicate C4-HSL C6-HSL 3-oxo-C12-HSL
Average mass [ng] in 10-ml sample 10.6 17.5 14.3
sR [ng] 3.7 3.8 2.9
RSDR [%] 35 22 20
Recovery [%] 54 89 79
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Sample sediments, which were obtained after the ini-
tial centrifuging of the ear rinses, were tested for residual
levels of AHLs prior to validation. This was performed
to verify the predominating distribution of analytes into
the liquid phase. Sediment analysis was the same as
implemented for the supernatants. The quantities of
individual AHLs were approximately 20-times lower
in the sediments than in their respective supernatants
(data not shown), indicating the residual level of less
than 5 %. Therefore, only supernatants were used for
further analysis.
Samples for the present study were collected from two
dogs with PaOE, which was confirmed with the routine
bacteriological analyses. The treatment regimen was
standard [53–58] and included regular ear irrigations
with topical saline flush and local administration of Tris-
EDTA/chlorhexidine (0.15 % solution; Otodin, Industria
Chimica Fine ICF, Palazzo Pignano, Italy) once daily.
Namely, the antiseptic solution Tris-EDTA/chlorhexi-
dine was proven beneficial and safe for the PaOE
diseased dogs with unlikely selection for bacterial resist-
ance which would predispose the chronic character of
the disease [55–58]. A systemic antibiotic (enrofloxacin)
treatment was only employed after clinical condition of
dogs deteriorated. To avoid confusion, the state of clin-
ical condition should not be directly deduced from the
results of culture examination or AHL content in the
samples. Enrofloxacin was administered in the last
14 days of treatment to the first dog and in the first
14 days to the second.
Regarding the total masses of AHLs in the ear lavages
of dogs with PaOE, the content of C6-HSL was in gen-
eral much lower than of C4-HSL, but the fluctuations of
these two roughly correlated. The content of C6-HSL
was approximating LOQ or even LOD. Moreover, the
content of 3-oxo-C12-HSL was always below LOQ or, in
most cases, below LOD. According to the results, only
C4-HSL measurements showed applicable value. In the
first dog, results showed that the content of C4-HSL de-
creased in the first month of Tris-EDTA/chlorhexidine
treatment in accordance to expectations [58], but in-
creased again toward the end of the treatment (slightly
in week 6 and markedly in week 8). The increase could
be assigned to a secondary infection of the ear canal,
Fig. 4 LC-MS/MS chromatogram of the ear rinse sample from a healthy dog, i.e., the representative chromatogram of a blank matrix. The noisy line
reflects only the negative background, as the y-axis scale was normalized to the largest peak of 7.800 × 102 units. Description of the axes as in Fig. 1
Fig. 5 LC-MS/MS chromatogram of the ear rinse sample from a dog with PaOE (P. aeruginosa-associated OE), i.e., the representative chromatogram of a
positive sample containing C4-HSL (N-butanoyl-L-homoserine lactone). The y-axis scale was normalized to the peak of 5.161 × 105 units. Chromatograms
for other clinical samples appeared similar when regarding detection of individual AHLs, due to the presentation of analyte quantity in relative units and
the characteristic analyte retention times. Description of the axes as in Fig. 1
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which was confirmed by culture examination showing
the presence of an additional P. aeruginosa strain.
In the second dog, the content of C4-HSL was below
LOD at the beginning of the disease management, but
increased after the first week of treatment. P. mirabilis, a
Gram-negative opportunistic pathogen ubiquitously
present in the environment and a common secondary
factor of OE in dogs [17, 18], was also isolated from the
ear canal. Since Gram-negative bacteria employ AHLs
for quorum communication, cross-talk communication
between the two species cannot be excluded. The inter-
species communication was suggested previously be-
tween P. aeruginosa and P. mirabilis, since a variation of
AHL QS system was observed in P. mirabilis with sig-
naling molecules being structurally similar to AHLs [59].
Namely, in both the cell-free culture supernatants of P.
aeruginosa and of P. mirabilis, compounds capable of
activating the AHL biosensor were found, not belonging
to AHLs but to structurally similar diketopiperazines
(DKPs). In concentration-dependent manner, DKPs were
able to activate the AHL biosensor, although their
physiological role remains to be discovered, but also
suggesting the existence of cross talk among bacterial
signaling systems. However, the QS system in Proteus sp.
is not completely understood and its signaling molecules
are not well defined. Although signaling molecules with
the structure identical to AHLs are not produced by P.
mirabilis [60], it was shown that P. mirabilis reacts and
changes the population features when AHLs produced
by other Gram-negative bacteria are added to the culture
media [61]. The content of C4-HSL in the second dog
decreased in the second week of treatment, which coin-
cided with the disappearance of P. mirabilis from the
bacteriological sample. The marked increase in C4-HSL
was detected in the third and fourth week, which coin-
cided with an additional strain of P. aeruginosa and the
reappearance of P. mirabilis in the bacteriological sam-
ple. After the fourth week, the C4-HSL content declined
and P. mirabilis was no longer present. By the end of
the treatment course, the additional strain of P. aerugi-
nosa also disappeared.
No AHLs were detected in the negative control sample
from a healthy dog. The analytical procedure described
and validated in this study is, therefore, capable of moni-
toring changes in AHL concentration throughout the
treatment regimen, reflecting the state of Pseudomonas
infection.
Concerning 3-oxo-C12-HSL, low concentrations were
detected in this study. Similar was observed previously
in samples from human patients with CF [7]. Several,
Table 4 Total masses of AHLs in the ear lavages of dogs with PaOE (Pseudomonas aeruginosa-associated OE), sampled in the course
of treatment
Day Week 1st dog
AHL mass [ng] Culture examinationa
C4-HSL C6-HSL 3-oxo-C12-HSL P. aeruginosa Other bacteria
0 0 33.7 1.1 <0.3 + –
7 1 26.7 1.1 <0.3 + –
14 2 29.4 1.2 <0.3 + –
21 3 15.3 1.2 <0.3 + –
28 4 1.3 <0.3 <0.3 + –
42 6 2.7 <0.3 <0.3 + (two strainsb) –
56 8 20.7 <1 <0.3 + (two strains) –
Day Week 2nd dog
AHL mass [ng] Culture examination
C4-HSL C6-HSL 3-oxo-C12-HSL P. aeruginosa Other bacteria
0 0 <0.3 <0.3 <0.3 + –
7 1 8.2 <0.3 <0.3 + Proteus mirabilis
14 2 1.9 <0.3 <0.3 + (two strains) –
21 3 21.2 1.6 <1 + (two strains) Proteus mirabilis
28 4 32.4 1.5 <1 + (two strains) Proteus mirabilis
42 6 3.1 <0.3 <0.3 + (two strains) –
56 8 3.4 <0.3 <0.3 + –
aResults of culture examination are given for better understanding and are explained in the text
bIndicating a secondary infection with a different P. aeruginosa strain, deteriorating the clinical condition of dogs and causing the increase of AHL content in the
infected ear canal
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interconnected or independent, reasons for this analytical
outcome are possible: i) 3-oxo-C12-HSL is not a major
AHL present in the ear canals of PaOE-diseased dogs or
in clinical samples in general; ii) deficiency of one or more
P. aeruginosa QS components leading to reduced synthe-
sis/deployment of 3-oxo-C12-HSL; iii) the in-vitro results,
which are presently the gold standard for understanding
the biology of QS and AHLs, are different from the in-
vivo behavior of P. aeruginosa QS; and iv) limitations of
the membrane transport, which are selective to effusion of
3-oxo-C12-HSL from P. aeruginosa cytoplasm.
Regarding the results obtained in this study and previ-
ously for the samples from human CF patients [7], it is
possible that 3-oxo-C12-HSL is not a major AHL
present in clinical samples, disease-related or in general.
One should not be misled by the terminology that the
rhl system is ‘only’ subordinate to las, as we can specu-
late that rhl might be more adaptable to current condi-
tions in its milieu or could support greater part of QS
communication. A deficiency of one or more QS com-
ponents of the rhl system was previously reported for P.
aeruginosa canine OE isolates [62], and P. aeruginosa
mutants with the impaired las were also obtained from
clinical samples [63]. These QS deficient strains are
regularly isolated from clinical or environmental samples
and are called the ‘cheating’ individuals, profiting from
the benefits of the cooperating population without con-
tributing to the community [64]. Not all P. aeruginosa
strains/isolates produce both C4-HSL and 3-oxo-C12-
HSL [7, 63]. In addition to the QS deficiencies, the ex-
pression of QS is different in P. aeruginosa isolates from
clinical samples or grown as biofilms when compared to
those that are grown in laboratory as broth cultures in
nutrient-rich media [12, 65]. Broth cultures are being
intensively studied to explain the composition and hier-
archy of bacterial QS systems. In the natural environ-
ments, however, biofilms are predominating over the
planktonic growth [7, 12]. P. aeruginosa is notorious for
its ability to form biofilms [10]. Isolated from CF sputum
of human patients, P. aeruginosa produces C4-HSL in
excess of 3-oxo-C12-HSL when grown in biofilms but
not in broth cultures [65]. If the higher content of C4-
HSL over 3-oxo-C12-HSL observed in the present study
is due to variation in their production, P. aeruginosa
from the ear canals of PaOE-diseased dogs is also pre-
dominantly present as biofilms. Another reason for low
concentrations of 3-oxo-C12-HSL in the studied clinical
samples, in addition to QS deficiencies of P. aeruginosa
strains and differential gene expression in biofilms, could
be the fact that 3-oxo-C12-HSL requires an active mem-
brane transport (pump) for its efflux from the cells to the
surroundings, whereas C4-HSL diffusion has no such
limitation and P. aeruginosa cells are freely permeable to
C4-HSL [7, 66].
If P. aeruginosa is predominately growing in biofilms
in the ear canals of PaOE-diseased dogs, another explan-
ation for the low amounts of 3-oxo-C12-HSL can be
suggested. Namely, AHLs are restricted in diffusion by
the extracellular matrix of biofilms and they reach
adequate intracellular concentrations for induction of
QS-dependent genes at lower values in comparison to
planktonic growth phenotype [67]. Therefore, it is pos-
sible that less 3-oxo-C12-HSL is needed in biofilms for
the activation of the subordinate rhl system, but more
with planktonic phenotypes due to diffusion throughout
the liquid milieu to reach concentrations high enough
for the activation of rhl.
P. aeruginosa can adapt to different environments via
its regulatory networks and multifunctional signal mole-
cules [34, 36], which can be monitored using the methods
such as the one reported in this study. Disrupting QS
regulation is a valuable approach to develop new thera-
peutic strategies. Implementation of alternative therapies
(QQ strategies) for PaOE, or other P. aeruginosa infec-
tions, should have a beneficial impact on patients [68, 69].
Plants, for example, represent a large and unexplored pool
of potentially QQ bioactive compounds [70, 71].
Conclusions
The QS system is a defining part of the pathologies
caused by P. aeruginosa and other bacteria. Detection
and quantification of AHLs in clinical samples may
provide an important diagnostic and prognostic tool to
follow the disease progress, which has already been
proven in human CF cases. It would also be possible to
initiate and/or terminate, or evaluate, the success of
antibiotic treatments in diseases of the PaOE complex-
ity. In this study, the LC-MS/MS analytical procedure
for determination of selected P. aeruginosa AHLs (C4-
HSL, C6-HSL, 3-oxo-C12-HSL) in clinical samples
obtained from PaOE-diseased dogs was introduced and
successfully validated. For the clinical samples obtained
from two PaOE-diseased dogs, low content of 3-oxo-
C12-HSL was observed with C4-HSL predominating. To
explain the phenomenon, it was suggested, in addition
to other hypotheses, that P. aeruginosa is growing in the
infected ear canals organized in biofilms.
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